Published in Miner Electrolyte Metab on January 01, 1985
The quality of life of patients with end-stage renal disease. N Engl J Med (1985) 5.10
Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol (1976) 2.93
Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet (1971) 2.64
Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int (1997) 2.54
Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes (1983) 1.89
Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism. J Clin Endocrinol Metab (1988) 1.87
Measurement of glomerular filtration rate utilizing a single subcutaneous injection of 125I-iothalamate. Kidney Int (1973) 1.80
Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med (1995) 1.75
Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol (1993) 1.73
Treatment of postmenopausal osteoporosis with slow-release sodium fluoride. Final report of a randomized controlled trial. Ann Intern Med (1995) 1.72
A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Engl J Med (1975) 1.71
Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol (1997) 1.67
Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med (1984) 1.67
Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol (1999) 1.63
Clinical and biochemical presentation of gouty diathesis: comparison of uric acid versus pure calcium stone formation. J Urol (1995) 1.60
Treatment with thyrocalcitonin of the hypercalcemia of parathyroid carcinoma. J Clin Endocrinol Metab (1968) 1.55
Physicochemical basis for formation of renal stones of calcium phosphate origin: calculation of the degree of saturation of urine with respect to brushite. J Clin Invest (1969) 1.54
Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med (1980) 1.50
The effect of calcium citrate on bone density in the early and mid-postmenopausal period: a randomized placebo-controlled study. Am J Ther (1999) 1.49
Living kidney donation: a survey of professional attitudes and practices. Am J Kidney Dis (1997) 1.47
Slow-release sodium fluoride in the management of postmenopausal osteoporosis. A randomized controlled trial. Ann Intern Med (1994) 1.45
Assay of urinary oxalate: six methodologies compared. Clin Chem (1983) 1.44
The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. J Clin Invest (1974) 1.43
A further study of oxalate bioavailability in foods. J Urol (1990) 1.43
The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest (1977) 1.37
The role of dietary sodium on renal excretion and intestinal absorption of calcium and on vitamin D metabolism. J Clin Endocrinol Metab (1982) 1.36
Influence of the emetic reflex on vasopressin release in man. Kidney Int (1979) 1.31
The potential role of salt abuse on the risk for kidney stone formation. J Urol (1993) 1.31
Normocalcemic primary hyperparathyroidism. Am J Med (1969) 1.30
Heterologous serum-induced cellular alterations in the renal papilla. In vitro studies. Arch Pathol (1970) 1.29
Drug substitution in transplantation: a National Kidney Foundation White Paper. Am J Kidney Dis (1999) 1.29
The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects. J Bone Miner Res (1998) 1.29
Biochemical profile of idiopathic uric acid nephrolithiasis. Kidney Int (2001) 1.26
Mechanism for calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate. J Clin Invest (1977) 1.23
Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytes. J Biol Chem (1979) 1.22
Low urinary citrate excretion in nephrolithiasis. Urology (1983) 1.22
Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia. Diabetes (1988) 1.20
Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int (1983) 1.20
Metabolic effects of parathyroidectomy in asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab (1976) 1.20
Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med (1987) 1.19
Relationship between cytomegalovirus and hepatic function abnormalities in the period after renal transplant. J Infect Dis (1974) 1.18
Prospective comparative study of variable dosage and variable frequency regimens for administration of gentamicin. Antimicrob Agents Chemother (1975) 1.16
Effect of orange juice consumption on urinary stone risk factors. J Urol (1993) 1.16
Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res (1992) 1.15
Urinary excretion of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate. N Engl J Med (1972) 1.15
The current role of medical treatment of nephrolithiasis: the impact of improved techniques of stone removal. J Urol (1985) 1.15
Spontaneous precipitation of brushite in urine: evidence that brushite is the nidus of renal stones originating as calcium phosphate. Proc Natl Acad Sci U S A (1971) 1.15
Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate. N Engl J Med (1974) 1.14
Lack of autologous neutralizing antibody to human immunodeficiency virus type 1 (HIV-1) and macrophage tropism are associated with mother-to-infant transmission. J Infect Dis (1999) 1.13
The clinical spectrum of chronic metabolic acidosis: homeostatic mechanisms produce significant morbidity. Am J Kidney Dis (1997) 1.13
Effect of medical management and residual fragments on recurrent stone formation following shock wave lithotripsy. J Urol (1995) 1.13
Successful management of uric acid nephrolithiasis with potassium citrate. Kidney Int (1986) 1.12
Reduction of dietary phosphorus absorption by phosphorus binders. A theoretical, in vitro, and in vivo study. J Clin Invest (1989) 1.12
Hydrochlorothiazide therapy in nephrolithiasis. Effect on the urinary activity product and formation product of brushite. Clin Pharmacol Ther (1973) 1.11
Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate. Arch Intern Med (1986) 1.11
Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis. J Urol (1985) 1.11
Rhabdomyolysis and shock after intravenous amphetamine administration. Ann Intern Med (1977) 1.10
Sustained reduction in urinary calcium during long-term treatment with slow release neutral potassium phosphate in absorptive hypercalciuria. J Urol (1998) 1.10
Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24. J Clin Endocrinol Metab (1999) 1.10
Emergence of insulin receptors upon alloimmune T cells in the rat. J Clin Invest (1977) 1.09
Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Lab Anal (1999) 1.08
Letter: Chronic phycomycosis in a controlled diabetic. Ann Intern Med (1974) 1.08
Should patients with single renal stone occurrence undergo diagnostic evaluation? J Urol (1982) 1.08
Jejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D. J Clin Invest (1981) 1.08
The effects of smoking on bone metabolism. Osteoporos Int (2012) 1.07
Gastrointestinal calcium absorption in nephrolithiasis. J Clin Endocrinol Metab (1972) 1.07
Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol (1986) 1.06
Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate. Proc Soc Exp Biol Med (1975) 1.06
The response of arginine vasopressin to intravenous ethanol and hypertonic saline in man: the impact of aging. J Gerontol (1978) 1.06
Alpha 1-antitrypsin excretion in stool in normal subjects and in patients with gastrointestinal disorders. Gastroenterology (1990) 1.04
The insulin receptor as a universal marker of activated lymphocytes. Eur J Immunol (1978) 1.04
Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Miner Res (1995) 1.04
An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab (1979) 1.04
Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate. Ann Intern Med (1986) 1.03
Thyroid function and metabolic state in chronic renal failure. Ann Intern Med (1976) 1.03
The treatment of osteoporosis with calcium infusions. Clinical studies. Am J Med (1969) 1.03
Jejunal and ileal absorption in patients with chronic renal disease. Effect of 1alpha-hydroxycholecalciferol. J Clin Invest (1976) 1.03
Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol (1985) 1.03
Spectrum of liver disease in renal transplant recipients. Gastroenterology (1975) 1.02
Specific insulin binding site on T and B lymphocytes as a marker of cell activation. Nature (1978) 1.00
The hypercalciuria of diabetes mellitus: its amelioration with insulin. Clin Endocrinol (Oxf) (1978) 1.00
Thiazide diuretics and calcium metabolism. Metabolism (1973) 0.99
Impaired adaptation to salt-induced urinary calcium losses in postmenopausal osteoporosis. Trans Assoc Am Physicians (1985) 0.99
Probable Mycobacterium fortuitum septicemia: complication of home dialysis. Lancet (1971) 0.99
Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures. J Clin Endocrinol Metab (1989) 0.99
Preferential infiltration of macrophages during early stages of insulitis in diabetes-prone BB rats. Diabetes (1988) 0.98